1. Home
  2. RNXT vs BGI Comparison

RNXT vs BGI Comparison

Compare RNXT & BGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • BGI
  • Stock Information
  • Founded
  • RNXT 2012
  • BGI 1879
  • Country
  • RNXT United States
  • BGI Canada
  • Employees
  • RNXT N/A
  • BGI N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • BGI
  • Sector
  • RNXT Health Care
  • BGI
  • Exchange
  • RNXT Nasdaq
  • BGI Nasdaq
  • Market Cap
  • RNXT 31.6M
  • BGI 23.4M
  • IPO Year
  • RNXT 2021
  • BGI 2005
  • Fundamental
  • Price
  • RNXT $1.04
  • BGI $1.21
  • Analyst Decision
  • RNXT Strong Buy
  • BGI
  • Analyst Count
  • RNXT 1
  • BGI 0
  • Target Price
  • RNXT $9.00
  • BGI N/A
  • AVG Volume (30 Days)
  • RNXT 226.9K
  • BGI 419.4K
  • Earning Date
  • RNXT 03-31-2025
  • BGI 11-27-2024
  • Dividend Yield
  • RNXT N/A
  • BGI N/A
  • EPS Growth
  • RNXT N/A
  • BGI N/A
  • EPS
  • RNXT N/A
  • BGI N/A
  • Revenue
  • RNXT N/A
  • BGI $131,596,264.00
  • Revenue This Year
  • RNXT N/A
  • BGI N/A
  • Revenue Next Year
  • RNXT N/A
  • BGI N/A
  • P/E Ratio
  • RNXT N/A
  • BGI N/A
  • Revenue Growth
  • RNXT N/A
  • BGI 4.01
  • 52 Week Low
  • RNXT $0.77
  • BGI $1.03
  • 52 Week High
  • RNXT $1.86
  • BGI $3.98
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 32.70
  • BGI 37.25
  • Support Level
  • RNXT $1.00
  • BGI $1.03
  • Resistance Level
  • RNXT $1.18
  • BGI $1.54
  • Average True Range (ATR)
  • RNXT 0.10
  • BGI 0.19
  • MACD
  • RNXT -0.04
  • BGI -0.05
  • Stochastic Oscillator
  • RNXT 8.00
  • BGI 18.00

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About BGI Birks Group Inc.

Birks Group Inc is a part of the leisure industry. The company designs, develops, produces, and retails fine jewelry, timepieces, and gifts. Its operating segments include Retail and Other. The company generates maximum revenue from the Retail segment. Its retail segment consists of retail operations whereby it operates stores in Canada under the Maison Birks, Brinkhaus, Graff, and Patek Phillippe brands. The other segment consists mainly of wholesale business, e-commerce business, and gold exchange business.

Share on Social Networks: